** Shares of geospatial services provider Genesys
International Corporation GENS.NS settle 8.5% higher at 821
rupees, log their best day since late August
** Elara Capital intiates coverage on stock with "buy"
rating and TP of 1,370 rupees, implying upside of 81% on co's
Friday close
** GENE is poised for robust growth fueled by its leadership
in 3D mapping in India, Elara says
** Expects GENE's revenue to grow at CAGR of 54% between
FY24-27, PAT at CAGR of 89%
** Elara says co's leadership in 3D Digital Twin technology,
AI-driven mapping enables it to secure high value contracts
** GENS has doubled in 2024
(Reporting by Nishit Navin)
((nishit.navin@thomsonreuters.com;))